WHO Resumes Hydroxychloroquine Trials For COVID-19

WHO resumes trial of hydroxychloroquine for COVID-19 After temporarily
halting study over safety concerns, WHO resumes its trial on
hydroxychloroquine – the malaria drug backed by Donald Trump to fight
COVID-19. Tedros Adhanom Ghebreyesus, WHO Director-General said during
a press conference at the agency's Geneva head office that the Data
Safety Monitoring Board decided there […]

The post WHO Resumes Hydroxychloroquine Trials For COVID-19 appeared
first on BioTecNika .

https://www.biotecnika.org/2020/06/who-resumes-trial-of-hydroxychloroquine-for-covid-19/

Biotech News